The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Mutational load (ML) and T-cell-inflamed microenvironment as predictors of response to pembrolizumab.
 
Razvan Cristescu
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Robin Mogg
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Mark Ayers
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Andrew Albright
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Erin Murphy
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Jennifer Yearley
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Xinwei Sher
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Xiaoqiao Liu
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Michael Nebozhyn
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Jared K. Lunceford
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Andrew K. Joe
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Jonathan Cheng
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Elizabeth R. Plimack
Consulting or Advisory Role - Acceleron Pharma; Bristol-Myers Squibb; Dendreon; Genentech/Roche; GlaxoSmithKline; Merck; Novartis; Pfizer
Research Funding - Acceleron Pharma (Inst); Acerta Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - U.S. Patent No.: 14/588,503, Filed 1/2/2015. (Inst)
 
Patrick Alexander Ott
Consulting or Advisory Role - Alexion Pharmaceuticals; Amgen; Bristol-Myers Squibb; Celldex; CytomX Therapeutics; Genentech; Neon Therapeutics
Research Funding - ARMO BioSciences (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Merck (Inst)
 
Tanguy Y. Seiwert
Honoraria - Amgen; AstraZeneca; Bayer/Onyx; Bristol-Myers Squibb; Merck; Merck Serono
Research Funding - Boehringer Ingelheim (Inst); Genentech/Roche (Inst)
 
Terrill K McClanahan
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Andrey Loboda
Employment - Merck
Stock and Other Ownership Interests - Merck
 
David Ross Kaufman
Employment - Merck
Stock and Other Ownership Interests - Merck